Mar 06, 2018
Eiger BioPharmaceuticals to Participate in U.S. and International Investor and Partnership Conferences in March
Mar 05, 2018
Eiger Announces Abstracts and Presentations of LOWR HDV Program and Planned Registration Program at The International Liver Congress(TM) Meeting
Feb 06, 2018
Eiger BioPharmaceuticals to Participate in Two Upcoming Investor Conferences in February
Jan 16, 2018
Eiger BioPharmaceuticals Announces Phase 2 LIBERTY Study in Pulmonary Arterial Hypertension Did Not Meet Primary Endpoint
Jan 08, 2018
Eiger BioPharmaceuticals Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors
Jan 04, 2018
Eiger BioPharmaceuticals Completes Enrollment of Phase 2 ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients
Jan 03, 2018
Eiger BioPharmaceuticals Appoints David Apelian, MD, PhD, MBA Chief Operating Officer and Executive Medical Officer
Jan 02, 2018
Eiger BioPharmaceuticals to Present at Biotech Showcase(TM) 2018
Nov 13, 2017
Eiger BioPharmaceuticals to Present at Jefferies 2017 Healthcare Conference
Nov 09, 2017
Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results
Nov 06, 2017
Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences
Oct 31, 2017
Eiger BioPharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise In Full of Underwriter's Option to Purchase Additional Shares
Oct 27, 2017
Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock
Oct 26, 2017
Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock
Oct 23, 2017
Eiger Announces Positive Phase 2 Interim 24-Week Data with Pegylated Interferon Lambda in Hepatitis Delta Virus (HDV) Infection at the American Association for the Study of Liver Diseases (AASLD) Meeting
Oct 02, 2017
Eiger Announces Abstracts and Presentations at the American Association for the Study of Liver Diseases (AASLD) Meeting
Sep 18, 2017
Eiger Announces Appointment of Biopharmaceutical Industry Veteran Evan Loh, MD to its Board of Directors
Sep 05, 2017
Eiger Announces FDA Orphan Drug Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection
Aug 30, 2017
Eiger BioPharmaceuticals to Present at Two Upcoming Investor Conferences
Aug 14, 2017
Eiger BioPharmaceuticals Reports Second Quarter 2017 Financial Results